Jupiter Neurosciences

JUNSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.771 M

$2.86 -4.98%

Close of 18 Sept 2026

Revenue

$21.8K

#3623 by revenue

Earnings

-$8.64M

Loss-making

Shares outstanding

770,081

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#470Cadrenal TherapeuticsCVKD$3.82M
#471CapstoneCAPS$3.81M
#472Jupiter NeurosciencesJUNS$3.77M
#473Revelation BiosciencesREVB$3.71M
#474Galmed PharmaceuticalsEOCN$3.51M

What if Jupiter Neurosciences were worth as much as…

Open the what-if tool →

Gold $30.4T

$23,046,625

Per share 8,058,261× higher

Bitcoin $1.64T

$1,240,805

Per share 433,848× higher

Nvidia $5.36T

$4,062,663

Per share 1,420,512× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Jupiter Neurosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.